Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here Is What Hedge Funds Think About Repligen Corporation (RGEN)

Page 1 of 2

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in these filings, which are based on their September 30 holdings, data that is available nowhere else. Should you consider Repligen Corporation (NASDAQ:RGEN) for your portfolio? We’ll look to this invaluable collective wisdom for the answer.

Among the funds we track, Repligen Corporation (NASDAQ:RGEN) was in 14 hedge funds’ portfolios at the end of the third quarter of 2015, unchanged on the quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Green Dot Corporation (NYSE:GDOT), Albany International Corp. (NYSE:AIN), and PTC Therapeutics, Inc. (NASDAQ:PTCT) to gather more data points.

Follow Repligen Corp (NASDAQ:RGEN)
Trade (NASDAQ:RGEN) Now!

In the 21st century investor’s toolkit, there are a lot of metrics shareholders employ to appraise stocks. Two of the most underrated metrics are hedge fund and insider trading signals. We have shown that, historically, those who follow the best picks of the top fund managers can outclass their index-focused peers by a solid amount (see the details here).

Now, we’re going to review the latest action regarding Repligen Corporation (NASDAQ:RGEN).

What does the smart money think about Repligen Corporation (NASDAQ:RGEN)?

At the end of the third quarter, a total of 14 of the hedge funds tracked by Insider Monkey held long positions in this stock, unchanged in comparison to the second quarter. With the smart money’s capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Renaissance Technologies has the largest position in Repligen Corporation (NASDAQ:RGEN), worth close to $24.4 million, accounting for 0.1% of its total 13F portfolio. The second most bullish fund manager is Clifford Fox of Columbus Circle Investors, with a $11.8 million position; 0.1% of Columbus’ 13F portfolio is allocated to the stock. Remaining hedge funds and institutional investors that are bullish encompass Israel Englander’s Millennium Management, Robert B. Gillam’s McKinley Capital Management and Richard Driehaus’ Driehaus Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!